Akel Marwan, Hajj Aline, Sacre Hala, Zeenny Rony M, Haddad Chadia, Salameh Pascale
INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon.
School of Pharmacy, Lebanese International University, Beirut, Lebanon.
J Pharm Policy Pract. 2022 Nov 17;15(1):83. doi: 10.1186/s40545-022-00485-1.
Pharmaceutical research can be structured into clear national strategies that optimize patient health and foster innovation. The objectives of this document are to assess the need for a national pharmaceutical research strategy based on the current situation in Lebanon, to identify the strengths and weaknesses of pharmaceutical research in Lebanon, and to suggest a pharmaceutical research strategy for Lebanon, including goals and objectives. In Lebanon, in the absence of a national health research policy, pharmaceutical research is conducted in academia or hospitals, although projects are the result of personal or team initiatives that should be organized to better serve the needs of the country. Many strengths of pharmaceutical research were identified, such as the pharmaceutical workforce and academics who are willing to contribute to research, while the implementation of the national pharmaceutical strategy represents an important opportunity to promote research. Among the weaknesses is the lack of research culture in some institutions and interinstitutional/interprofessional collaborations. Thus, the suggested strategy aims to structure pharmaceutical research in Lebanon, including the priorities towards which research is directed, the process by which research is conducted, and the workforce conducting research. It will mainly rely on the World Health Organization's interrelated goals (organization, priorities, capacity, standards, and translation). The implementation of the suggested pharmaceutical research strategy will only be achieved through the leadership of the pharmaceutical authorities and the collaboration of stakeholders.
药物研究可以构建成明确的国家战略，以优化患者健康并促进创新。本文档的目的是根据黎巴嫩的现状评估制定国家药物研究战略的必要性，确定黎巴嫩药物研究的优势和劣势，并为黎巴嫩提出一项药物研究战略，包括目标和宗旨。在黎巴嫩，由于缺乏国家卫生研究政策，药物研究在学术界或医院开展，尽管项目是个人或团队自发进行的，但应加以组织，以更好地满足国家需求。已确定了药物研究的许多优势，例如愿意为研究做出贡献的药学专业人员和学者，而实施国家药物战略是促进研究的重要契机。劣势之一是一些机构缺乏研究文化以及机构间/专业间合作不足。因此，建议的战略旨在构建黎巴嫩的药物研究体系，包括研究的重点方向、研究开展的流程以及进行研究的人员队伍。它将主要依赖世界卫生组织的相互关联目标（组织、重点、能力、标准和转化）。建议的药物研究战略只有通过药物管理部门的领导和利益相关者的合作才能得以实施。
